TFA Therapeutics, Inc.

Cordyceps Sunshine Biotech Holdings Co., Ltd. is a biotechnology company that develops, produces, and markets health and dietary supplement products. The company focuses primarily on the cultivation and deep processing of Cattle camphor mushroom, also known as Antrodia Cinnamomum, as well as Cordyceps fungi. Its product offerings include Chinese medicinal material products and dietary supplements marketed under the brand name Kasaer. The company supplies its products to third-party and related-party distributors and retailers, who in turn serve individual consumers.

The company maintains its principal executive offices in Taipei City, Taiwan, and is incorporated in the Cayman Islands. Its operational activities are conducted through its Taiwan branch, where it operates production facilities for mushroom cultivation and processing. The business relies on a single third-party vendor to supply all of its raw materials. Geographically, the company distributes and sells all of its merchandise outside the United States, exporting its dietary supplements from Taiwan to markets in mainland China and Hong Kong.

Summary of the business section of TFA Therapeutics's latest annual report, written by StockData.

“As of the date of this annual report, we have 16 full time employees on our payroll, among which 2 are in general administration, 2 are in accounting, 2 are in operation management, and 10 are in sales and marketing.”